Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF614 Analgesic Response in Cold Pressor Test
NCT06629402Phase 2Completed
- Sponsor
- Ensysce Biosciences
- Start
- Oct 2023
- Primary completion
- Nov 2023
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PF614 in acute pain, sponsored by Ensysce Biosciences. Started Oct 2023; status: completed.
02
Drugs
PF614
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT06629402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06629402.